English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/218415
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:

Title

Two antagonistic microtubule targeting drugs act synergistically to kill cancer cells

AuthorsPeronne, Lauralie; Denarier, Eric; Rai, Ankit; Prudent, Renaud; Vernet, Audrey; Suzanne, Peggy; Ramirez-Rios, Sacnicté; Michallet, Sophie; Guidetti, Mélanie; Vollaire, Julien; Lucena-Agell, Daniel ; Ribba, Anne-Sophie; Josserand, Véronique; Coll, Jean-Luc; Dallemagne, Patrick; Díaz, J. Fernando; Oliva, María A. ; Sadoul, Karin; Akhmanova, Anna; Andrieux, Annie; Lafanechère, Laurence
Keywordscancer therapy
microtubules
drug synergy
carbazole
paclitaxel
Issue Date6-Aug-2020
PublisherMultidisciplinary Digital Publishing Institute
CitationCancers 12(8): 2196 (2020)
AbstractPaclitaxel is a microtubule stabilizing agent and a successful drug for cancer chemotherapy inducing, however, adverse effects. To reduce the effective dose of paclitaxel, we searched for pharmaceutics which could potentiate its therapeutic effect. We screened a chemical library and selected Carba1, a carbazole, which exerts synergistic cytotoxic effects on tumor cells grown in vitro, when co-administrated with a low dose of paclitaxel. Carba1 targets the colchicine binding-site of tubulin and is a microtubule-destabilizing agent. Catastrophe induction by Carba1 promotes paclitaxel binding to microtubule ends, providing a mechanistic explanation of the observed synergy. The synergistic effect of Carba1 with paclitaxel on tumor cell viability was also observed in vivo in xenografted mice. Thus, a new mechanism favoring paclitaxel binding to dynamic microtubules can be transposed to in vivo mouse cancer treatments, paving the way for new therapeutic strategies combining low doses of microtubule targeting agents with opposite mechanisms of action.
Publisher version (URL)https://doi.org/10.3390/cancers12082196
URIhttp://hdl.handle.net/10261/218415
DOIhttp://dx.doi.org/10.3390/cancers12082196
E-ISSN2072-6694
Appears in Collections:(CIB) Artículos
Files in This Item:
File Description SizeFormat 
antagonistic_microtubule_drugs_kill_cancer_cells.pdf8,42 MBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.